Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study

References

• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. doi: 10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Beyrer, C., Baral, S. D., van Griensven, F., Goodreau, S. M., Chariyalertsak, S., Wirtz, A. L., & Brookmeyer, R. (2012). Global epidemiology of HIV infection in men who have sex with men. The Lancet, 380(9839), 367–377. doi: 10.1016/S0140-6736(12)60821-6
   PubMed Web of Science ®Google Scholar
• Bracchi, M., Stuart, D., Castles, R., Khoo, S., Back, D., & Boffito, M. (2015). Increasing use of “party drugs” in people living with HIV on antiretrovirals: A concern for patient safety. AIDS, 29(13), 1585–1592. doi: 10.1097/QAD.0000000000000786
   PubMed Web of Science ®Google Scholar
• CDC. (2012). HIV surveillance supplemental report: Estimated HIV incidence among adults and adolescents in the United States, 2007–2010. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/hiv/pdf/statistics_hssr_vol_17_no_4.pdf
   Google Scholar
• Creswell, J. (2013). Qualitative inquiry and research design: Choosing among five approaches. Thousand Oaks, CA: Sage.
   Google Scholar
• Daskalopoulou, M., Rodger, A., Phillips, A. N., Sherr, L., Speakman, A., Collins, S., … Wilkins, E. (2014). Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: Results from the cross-sectional ASTRA study. The Lancet HIV, 1(1), e22–e31. doi: 10.1016/S2352-3018(14)70001-3
   PubMed Web of Science ®Google Scholar
• Glaser, B. G., & Strauss, A. L. (2012). The discovery of grounded theory: Strategies for qualitative research (7th ed.). New York: Aldine Transaction.
   Google Scholar
• Golub, S. A., Kowalczyk, W., Weinberger, C. L., & Parsons, J. T. (2010). Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. JAIDS Journal of Acquired Immune Deficiency Syndromes, 54(5), 548–555. doi: 10.1097/QAI.0b013e3181e19a54
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Ramirez-Cardich, M. E. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. doi: 10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Halkitis, P. N., & Parsons, J. T. (2002). Recreational drug use and HIV-risk sexual behavior among men frequenting gay social venues. Journal of Gay & Lesbian Social Services: Issues in Practice, Policy & Research, 14(4), 19–38. doi: 10.1300/J041v14n04_02
   Google Scholar
• Hegazi, A., Lee, M. J., Whittaker, W., Green, S., Simms, R., Cutts, R., … Pakianathan, M. R. (2016). Chemsex and the city: Sexualised substance use in gay bisexual and other men who have sex with men attending sexual health clinics. International Journal of STD & AIDS, 28, 362–366. 0956462416651229. doi: 10.1177/0956462416651229
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., … Longshore, D. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11, 185–194. doi: 10.1007/s10461-006-9152-0
   PubMed Web of Science ®Google Scholar
• Holt, M. (2015). Configuring the users of new HIV-prevention technologies: The case of HIV pre-exposure prophylaxis. Culture Health & Sexuality, 17(4), 428–439. doi: 10.1080/13691058.2014.960003
   PubMed Web of Science ®Google Scholar
• Hoots, B. E., Finlayson, T., Nerlander, L., & Paz-Bailey, G.for the NHBS Study Group. (2016). Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men—20 US cities, 2014. Clinical Infectious Diseases, 63(5), 672–677. doi: 10.1093/cid/ciw367
   PubMed Web of Science ®Google Scholar
• Kirby, T., & Thornber-Dunwell, M. (2014). Uptake of PrEP for HIV slow among MSM. The Lancet, 383(9915), 399–400. doi: 10.1016/S0140-6736(14)60137-9
   PubMed Web of Science ®Google Scholar
• Krakower, D. S., & Mayer, K. H. (2012). Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Current Opinion in HIV and AIDS, 7(6), 593–599. doi: 10.1097/COH.0b013e3283590446
   PubMed Web of Science ®Google Scholar
• Krakower, D. S., Mimiaga, M. J., Rosenberger, J. G., Novak, D. S., Mitty, J. A., White, J. M., & Mayer, K. H. (2012). Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE, 7(3), e33119. doi: 10.1371/journal.pone.0033119
   PubMed Web of Science ®Google Scholar
• Krieger, N. (2001). Theories for social epidemiology in the 21st century: An ecosocial perspective. International Journal of Epidemiology, 30, 668–677. doi: 10.1093/ije/30.4.668
   PubMed Web of Science ®Google Scholar
• Mansergh, G., Colfax, G. N., Marks, G., Rader, M., Guzman, R., & Buchbinder, S. (2001). The circuit party men’s health survey: Findings and implications for gay and bisexual men. American Journal of Public Health, 91(6), 953–958. doi: 10.2105/AJPH.91.6.953
   PubMed Web of Science ®Google Scholar
• Marquez, C., Mitchell, S. J., Hare, C. B., John, M., & Klausner, J. D. (2009). Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004–2006. AIDS Care, 21(5), 575–582. doi: 10.1080/09540120802385579
   PubMed Web of Science ®Google Scholar
• Mattison, A. M., Ross, M. W., Wolfson, T., & Franklin, D. R. (2001). Circuit party attendance, club drug use, and unsafe sex in gay men. Journal of Substance Abuse, 13(1-2), 119–126. doi: 10.1016/S0899-3289(01)00060-8
   PubMedGoogle Scholar
• Mayer, K. H., Colfax, G., & Guzman, R. (2006). Club drugs and HIV infection: A review. Clinical Infectious Diseases, 42(10), 1463–1469. doi: 10.1086/503259
   PubMed Web of Science ®Google Scholar
• Meyers, K., Rodriguez, K., Moeller, R. W., Gratch, I., Markowitz, M., & Halkitis, P. N. (2014). High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: A P18 cohort substudy. PLoS ONE, 9(12), e114700. doi: 10.1371/journal.pone.0114700
   PubMed Web of Science ®Google Scholar
• Mimiaga, M. J., Case, P., Johnson, C. V., Safren, S. A., & Mayer, K. H. (2009). Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: Limited knowledge and experience but potential for increased utilization after education. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50(1), 77–83. doi: 10.1097/QAI.0b013e31818d5a27
   PubMed Web of Science ®Google Scholar
• Molina, J.-M. (2016, July). PrEP rollout in France. Paper presented at the 21st international AIDS conference, Durban, South Africa.
   Google Scholar
• Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., … Raffi, F. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373(23), 2237–2246. doi: 10.1056/NEJMoa1506273
   PubMed Web of Science ®Google Scholar
• Molina, J.-M., Charreau, I., Spire, B., Cotte, L., Chas, J., Capitant, C., & Meyer, L.for the ANRS IPERGAY Study Group. (2016, July). Efficacy of on demand PrEP with TDF-FTC in the ANRS IPERGAY open-label extension study. Paper presented at the 21st international AIDS conference, Durban, South Africa.
   Google Scholar
• Mugo, P. M., Sanders, E. J., Mutua, G., van der Elst, E., Anzala, O., Barin, B., … Haberer, J. E. (2014). Understanding adherence to daily and intermittent regimens of oral HIV pre-exposure prophylaxis among men who have sex with men in Kenya. AIDS and Behavior, 19(5), 794–801. doi: 10.1007/s10461-014-0958-x
   Web of Science ®Google Scholar
• Phua, V. (2004). Convenience sample. In The SAGE encyclopedia of social science research methods (Vol. 1, p. 197). Thousand Oaks, CA: Sage.
   Google Scholar
• Reback, C. J., Larkins, S., & Shoptaw, S. (2003). Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care, 15(6), 775–785. doi: 10.1080/09540120310001618621
   PubMed Web of Science ®Google Scholar
• Roberts, S. T., Heffron, R., Ngure, K., Celum, C., Kurth, A., Curran, K., … Baeten, J. M. (2014). Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples. AIDS and Behavior, 18(9), 1701–1711. doi: 10.1007/s10461-014-0804-1
   PubMed Web of Science ®Google Scholar
• Rocha, L. M., Campos, M. J., Brito, J., Fuertes, R., Rojas, J., Pinto, N., … Esteves, J. (2014). Acceptability of PrEP among HIV negative Portuguese men who have sex with men that attended 2014 Lisbon pride fair. Journal of the International AIDS Society, 17(4 Suppl 3), 19734.
   PubMedGoogle Scholar
• Ross, M. W., Mattison, A. M., & Franklin, D. R. (2003). Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men. Substance Use & Misuse, 38(8), 1173–1183. doi: 10.1081/JA-120017657
   PubMed Web of Science ®Google Scholar
• Sandelowski, M. (2010). What’s in a name? Qualitative description revisited. Research in Nursing and Health, 33(1), 77–84.
   PubMed Web of Science ®Google Scholar
• Silverman, D. (2010). Doing qualitative research: A practical handbook (3rd ed.). Thousand Oaks, CA: Sage.
   Google Scholar
• Spector, A. Y., Remien, R. H., & Tross, S. (2015). PrEP in substance abuse treatment: A qualitative study of treatment provider perspectives. Substance Abuse Treatment, Prevention, and Policy, 10, 1. doi: 10.1186/1747-597X-10-1
   PubMed Web of Science ®Google Scholar
• Taylor, W. S., Mayer, K. H., Elsesser, S. M., Mimiaga, M. J., O’Cleirigh, C., & Safren, S. A. (2014). Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naive men. AIDS and Behavior, 18(5), 871–879. doi: 10.1007/s10461-013-0617-7
   PubMed Web of Science ®Google Scholar
• Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. doi: 10.1056/NEJMoa1110711
   PubMed Web of Science ®Google Scholar
• Van der Elst, E. M., Mbogua, J., Operario, D., Mutua, G., Kuo, C., Mugo, P., … Priddy, F. (2013). High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: Qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS and Behavior, 17(6), 2162–2172. doi: 10.1007/s10461-012-0317-8
   PubMed Web of Science ®Google Scholar
• WHO. (2014). Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva: The World Health Organization. Retrieved from http://www.who.int/hiv/pub/guidelines/keypopulations/en/
   Google Scholar
• Young, I., & McDaid, L. (2014). How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS and Behavior, 18(2), 195–216. doi: 10.1007/s10461-013-0560-7
   PubMed Web of Science ®Google Scholar